HeadacheJournal Profile Banner
Headache Journal Profile
Headache Journal

@HeadacheJournal

Followers
7K
Following
2K
Media
2K
Statuses
5K

The official journal of the American Headache Society @ahsheadache | Follow also on Instagram: https://t.co/A5sXQbAYSK

Joined April 2013
Don't wanna be here? Send us removal request.
@HeadacheJournal
Headache Journal
1 day
As we start the academic year in medicine, check out this collection of Essential Readings for trainees in #Headache Medicine, curated by Assistant Editors Drs. Manali Nigam & Nan Cheng!.
Tweet media one
0
0
1
@HeadacheJournal
Headache Journal
2 days
RT @NoheadachesNoah: Big thanks to all of my collaborators! It is great to see that we are moving the needle in #Migraine care and are abl….
0
1
0
@HeadacheJournal
Headache Journal
2 days
Open Access:.A retrospective claims data study finds a reduction in #opioid & #barbiturate use for any reason after initiation of #rimegepant for #migraine prevention.@NoheadachesNoah @HyggePhD et al.
Tweet media one
0
2
7
@HeadacheJournal
Headache Journal
2 days
Underscoring the need for detailed history taking when patients present w #headache, including OTC product use, authors report a case of #hypervitaminosesA causing #papilledema & #IIH, presumably caused by long-term use of #retinol-containing day cream.
0
0
1
@HeadacheJournal
Headache Journal
2 days
RT @PatientCV: Patient preferences medicating headache.
0
1
0
@HeadacheJournal
Headache Journal
6 days
Open Access:.Serial occipital nerve blocks are a safe & potentially effective option for #migraine treatment during #pregnancy, with ⬆️ QoL, no significant pregnancy complications or negative fetal outcomes, & ⬇️ acute med use.@LizaSmirnoffmd et al
Tweet media one
0
5
16
@HeadacheJournal
Headache Journal
11 days
A longitudinal observational study & systematic review finds greater occipital nerve blocks to be effective & tolerated in children & adolescents for the management of chronic #headaches, particularly #migraine.Maria Morozova MD PhD et al
Tweet media one
0
8
28
@HeadacheJournal
Headache Journal
13 days
Open Access:.A dose-ranging, double-blind, randomized controlled trial demonstrates #rimegepant is effective & safe for the acute treatment of #migraine in Japan, supporting findings from clinical studies in other countries.Koichi Ikeda MD et al
Tweet media one
0
3
10
@HeadacheJournal
Headache Journal
13 days
RT @ahsheadache: #HeadacheHighlights . Prevalence of adverse childhood experiences in the refractory chronic migraine population compared t….
0
1
0
@HeadacheJournal
Headache Journal
14 days
Open Access:.A real-world survey identifies gaps in diagnosis & management of #menstrual #migraine, including differences in patient & clinician-reported attack severity & ⬇️ treatment satisfaction, allowing opportunities to improve care.G Terdwindt et al
Tweet media one
1
2
5
@HeadacheJournal
Headache Journal
14 days
Open Access:.The #rimegepant open-label extension data demonstrates continued safety & efficacy with #migraine prevention at 52 weeks.David Kudrow MD, Robert S. Croop MD, Alexandra Thiry PhD, Richard B. Lipton MD
Tweet media one
0
7
13
@HeadacheJournal
Headache Journal
14 days
RT @ahsheadache: The AHS Resident Education Program returns this fall, October 24-26, 2025 at the UCLA Luskin Conference Center in Los Ange….
0
2
0
@HeadacheJournal
Headache Journal
18 days
Open Access:.A serial transcranial Doppler study finds that early administration of #nimodipine may have a role in mitigating #vasoconstriction in patients with reversible cerebral vasoconstriction syndrome (#RCVS).Soohyun Cho MD PhD et al
Tweet media one
0
1
10
@HeadacheJournal
Headache Journal
21 days
Free Access:.Select scholarly works are translated into Plain Language Summaries - the latest is now available! .Efficacy of an educational website on #headaches in schoolchildren: A cluster randomized controlled trial.@Lisa_Marie_Rau et al.
0
3
3
@HeadacheJournal
Headache Journal
21 days
Open Access:.A discrete-choice experiment survey in adults w episodic #migraine found that, on average, respondents prefer an oral pill to injections or infusions, highlighting importance of patient preference in choosing treatments.@stephanieJnahas et al
Tweet media one
0
3
8
@HeadacheJournal
Headache Journal
21 days
Open Access:.A retrospective, population-based cohort study from southern Israel found #triptan usage did not increase CV risk among patients w #migraine, even in those w existing CV risk factors, where no formal contraindication exists.Ido Peles MD et al
Tweet media one
0
2
8
@HeadacheJournal
Headache Journal
22 days
Open Access:.A double-blind, randomized controlled trial demonstrated efficacy & safety of #rimegepant for preventive treatment of #migraine in Japan, supporting findings from previous studies & broadening them to a wider population.S Kitamura MD et al
Tweet media one
0
2
5
@HeadacheJournal
Headache Journal
23 days
In this first study to characterize ACE scores in those w refractory chronic #migraine recommended for inpatient infusion therapy, results are consistent w prior research demonstrating an association of ACE & migraine chronification.S Ahmad, M Levin
Tweet media one
0
2
10
@HeadacheJournal
Headache Journal
24 days
Open Access:.A pilot study identified ⬆️ rates of #insomnia in youth w continuous #headache, suggesting screening & targeted interventions focused on #sleep difficulties be incorporated into treatment plans.@Robert_Gibler @ScottWPowers @HersheyAndrew et al
Tweet media one
1
3
7
@HeadacheJournal
Headache Journal
25 days
Open Access:.A prospective pilot study demonstrates potential effectiveness & tolerability of #liraglutide as add-on treatment in patients with #obesity & high-frequency or chronic #migraine.Simone Braca MD et al
Tweet media one
0
2
7